SWOG clinical trial number
SWOG-9060

A Pilot Study Evaluation of Multimodality Treatment of Local Regional Esophageal Carcinoma, Phase II

Closed
Phase
Accrual
100%
Published
Abbreviated Title
A Pilot Study Evaluation of Multimodality Treatment of Local Regional Esophageal Carcinoma, Phase II
Activated
11/01/1991
Closed
03/01/1993

Research committees

Gastrointestinal Cancer

Publication Information Expand/Collapse

1996

Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060.

EA Poplin;J Jacobson;A Herskovic;TJ Panella;M Valdivieso;LF Hutchins;JS Macdonald Cancer 78(9):1851-1856

1995

Evaluation of multimodality treatment of locoregional esophageal carcinoma: SWOG 9060.

E Poplin;A Herskovic;J Jacobson;T Panella;J Macdonald ASCO 14:202(#486)

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/A022101

A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
Research Committee(s)
Gastrointestinal Cancer
Activated
01/10/2023
Open
SWOG Clinical Trial Number
S2107

Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
06/06/2022
Accrual
74%
Open
Phase
SWOG Clinical Trial Number
S2104

A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
Research Committee(s)
Gastrointestinal Cancer
Activated
10/14/2021
Accrual
28%
Open
Phase